Core Viewpoint - Dayu Biological is increasing its investment in pig farming despite ongoing pressure in the pig breeding industry, aiming to extend its industrial chain and stabilize its feed sales channels [2][4]. Company Summary - Dayu Biological's wholly-owned subsidiary, Shanxi Dayu Animal Husbandry Co., Ltd., plans to invest 50 million yuan in its other subsidiary, Puxian Dayu Smart Animal Husbandry Industry Development Co., Ltd., raising its registered capital from 30 million yuan to 80 million yuan [2]. - The company primarily focuses on the research, production, and sales of feed additives, feed, and veterinary drugs, and has faced performance fluctuations since its listing on the Beijing Stock Exchange in 2022, recording its first loss in 2023 [2]. - Financial data shows Dayu Biological's revenue for 2022, 2023, and 2024 was 157 million yuan, 161 million yuan, and 123 million yuan respectively, with net profits of 18.15 million yuan, -2.09 million yuan, and -23.94 million yuan [2]. Industry Summary - The pig farming industry is undergoing structural changes, with a trend towards large-scale operations replacing smallholder farms, impacting Dayu Biological's sales of feed and additives [3]. - The company is adopting a "company + farmer" model to address challenges from the changing structure of downstream farming, having established a fully-owned subsidiary for pig farming in 2024 with an investment of 100 million yuan [3]. - As of August 2025, the national breeding sow inventory reached 40.38 million heads, indicating high production capacity, while pig prices remain low, affecting the profitability of many listed pig companies [4].